By at least 70% NASDAQ: SCON is rising before the market opens for intensive trading. Yesterday, it gained 33.68% increasing the daily volume to 15,957,328 shares. Tech and biotech shares are facing steady growth as the public needs them to fight the pandemic.
As the company fell to the phase of recovering revenue so its stockholders could enjoy the earnings, taking debts and issuing shares are only sources to cover the losses. Since 2000’s Superconductor Technologies has been facing petty cash stock while competitors are keeping at expensive prices that one lot of shares can cost thousands.
SCON’s market capitalization is seriously overvalued, meanwhile, EPS (12 months) sticks to $-0.6950. The actual capitalization is far less than the market value hinting that the stock has a bold trust from potential investors.